OXOID LIMITED
- Shared products
- CLOSTRIDIUM DIFFICILE (CLOSTRIDIOIDES DIFFICILE), COMBINED PARAMETERS IN THE SAME PRODUCT - CLASS II, CRYPTOCOCCUS NEOFORMANS, RESPIRATORY SYNCYTIAL VIRUS (RSV), STREPTOCOCCUS
- Shared products
- CLOSTRIDIUM DIFFICILE (CLOSTRIDIOIDES DIFFICILE), COMBINED PARAMETERS IN THE SAME PRODUCT - CLASS II, CRYPTOCOCCUS NEOFORMANS, RESPIRATORY SYNCYTIAL VIRUS (RSV), STREPTOCOCCUS
- Shared products
- CLOSTRIDIUM DIFFICILE (CLOSTRIDIOIDES DIFFICILE), COMBINED PARAMETERS IN THE SAME PRODUCT - CLASS II, CRYPTOCOCCUS NEOFORMANS, RESPIRATORY SYNCYTIAL VIRUS (RSV), STREPTOCOCCUS
- Shared products
- CLOSTRIDIUM DIFFICILE (CLOSTRIDIOIDES DIFFICILE), COMBINED PARAMETERS IN THE SAME PRODUCT - CLASS II, MEIOS DE CULTURA E DISPOSITIVOS PARA O ENRIQUECIMENTO DE MEIOS, RESPIRATORY SYNCYTIAL VIRUS (RSV), STREPTOCOCCUS
- Shared products
- CLOSTRIDIUM DIFFICILE (CLOSTRIDIOIDES DIFFICILE), COMBINED PARAMETERS IN THE SAME PRODUCT - CLASS II, ESCHERICHIA COLI, RESPIRATORY SYNCYTIAL VIRUS (RSV)
Explore comprehensive manufacturer profile for OXOID LIMITED based in United Kingdom through Pure Global AI's free Brazil medical device database. This manufacturer has 14 products registered with ANVISA across 12 unique technical categories. Their regulatory history spans from Apr 24, 2017 to Sep 21, 2026.
This page provides detailed insights including 5 recent product registrations, 5 most popular products with STREPTOCOCCUS having 2 registrations, 1 registration holders including PHADIA DIAGNOSTICOS LTDA, and 5 key competitors with Eco Diagnostica Ltda sharing 5 products. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, enabling global MedTech companies to analyze market dynamics and identify opportunities.